ArticleEMBO molecular medicine2018

Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy.

Pablo Ranea-Robles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.